A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors.
| Image |  |
|---|---|
| Description | scientific article published on 28 March 2017 |
| Author/s |
author: Gun Min Kim Sang Joon Shin Sun Young Rha Joong Bae Ahn Hyun Cheol Chung |
| Publication date | March 28, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |